baber/WOPTO huggingface dataset:
Patent PT-865480-E (PT)
Inventor: WEVERS JEAN
IPC: C11D9/18
Filed: 1996-09-03
Abstract: The invention relates to a granular detergent composition comprising (i) a softening clay and (ii) a clay flocculating polymer, and to a process for making the composition. The composition is particularly useful in "softening-through-the-wash" products. The clay flocculating polymer is sieved or ground such that at least 95 % by weight of the clay flocculating polymer has a particle size of less than 250 micrometers, and preferably less than 150 micrometers, before adding it to the granular detergent composition.
Patent PT-816340-E (PT)
Inventor: SAITO YUZURU
IPC: C07D417/00
Filed: 1997-06-26
Abstract: A method of producing a compound represented by the formula: <CHEM> wherein R<1> stands for hydrogen or an optionally substituted alkyl or acyl group, which comprises reacting a compound represented by the formula: <CHEM> wherein R<1> is of the same meaning as defined above, and R<2> stands for an optionally halogenated alkyl group or an optionally substituted phenyl group with a compound represented by the formula: <CHEM> in a lower alcohol in the presence of an alkali metal or alkaline earth metal carbonate; the compound (III) being useful as starting compounds for producing thiazolidinedione derivatives having hypoglycemic and hypolipidemic activities.
Patent PT-977582-E (PT)
Inventor: LEHMANN PAUL
IPC: A61K31/715
Filed: 1997-03-18
Abstract: A pharmaceutical composition comprising 250-20,000 U of an EPO preparation and 5-20 mg of a Fe(III) complex is disclosed. This pharmaceutical composition is useful in treating anaemias as well or as haemodialysis patients.
Patent PT-896957-E (PT)
Inventor: HOENIG RUSSELL D
IPC: C03B9/38
Filed: 1998-08-06
Abstract: A hollow parison (P) of a glass container is formed from a gob of molten glass, the parison having a body portion (B) with a closed end and an open end. The body portion of the parison is formed in an annular blank mold (14). The parison also has a finish portion (F) at the open end of the body portion of the parison, the finish portion being formed by an annular neck mold (16) which is positioned against an end of the blank mold during the forming of the parison. An annular cage (26) surrounds a substantial axially extending portion of the blank mold. The annular cage receives cooling air and directs cooling air against cooling fins (24) on the exterior of the blank mold to cool the body portion of the parison while it is in the blank mold. Spent cooling fluid from the annular cage flows therefrom through an opening aligned with the open end of the body portion of the parison. The annular cage is axially slideable along the longitudinal central axis of the blank mold with respect to the blank mold and is biased away from the annular neck mold by a compression spring (32) that is trapped between an annular pressure plate (34) and a portion of the annular cage. Cooling air exiting from the opening in the annular cage is caused to flow past the annular neck mold to assist in cooling the finish portion of the parison by an annular skirt (36) that is positioned below the annular pressure plate toward the annular neck mold. <IMAGE>
Patent PT-975557-E (PT)
Inventor: RONIN VLADIMIR
IPC: C04B7/52
Filed: 1998-03-23
Abstract: A method of treating cement clinker by grinding the clinker in a tubular mill while charging water, gypsum, and, optionally, also a water-reduction agent to the mill at the same time. The water has a pH of from about 9 to about 13. A microfill agent and/or a water-reduction agent is mixed with said the high pH-value water to form a slurry, which is added to the clinker during the grinding process together with microfill agent and/or water-reduction agent in a dry state. The high pH value of the water can be obtained by electrolysis.
Patent PT-1012656-E (PT)
Inventor: URSEL WAUTHIER D
IPC: G02B30/00
Filed: 1998-05-12
Abstract: A device and a method for producing a stereoscopic image with horizontal parallax including diffracting electromagnetic rays emitted by an object to provide a first dispersion of dispersed electromagnetic rays in which a lateral deviation of the rays emitted by the object is obtained in a first deviation direction; collecting at least part of the dispersed electromagnetic rays by shooting the object with at least one lens to provide an image; projecting the image through at least one screen facility; and diffracting electromagnetic rays emitted during projection to provide a second dispersion and scattering the second dispersion by the at least one screen facility to form a stereoscopic image of the object in which a lateral deviation of the rays emitted during projection is obtained in a second deviation direction.
Patent PT-1135460-E (PT)
Inventor: MUTZEL RUPERT
IPC: C12M1/34
Filed: 1999-12-02
Abstract: The present invention relates to a method and a device for selecting accelerated proliferation of living cells in suspension. The culture apparatus (2) of the present invention enables cells to proliferate in suspension over unlimited periods of time. Natural selection results in the accumulation of genetic variants which are increasingly better adapted to the chosen culture conditions. The organisms used can be prokaryotic or eukaryotic. The organisms used can be naturally occurring organisms or genetically modified organisms. The culture apparatus of the present invention is also suitable for using continuous, periodical or conditional culture conditions. The physical and chemical characteristics of the culture media used can be chosen by the user. The requirement that a population of cells proliferates exclusively in suspension in continuous culture conditions is satisfied by the periodical transfer of the organism suspension from a first culture vessel into a second culture vessel. After the transfer, the first culture vessel is subjected to a sterilizing treatment and the sterilizing agent is optionally neutralized, so that the first culture vessel is ready for the culture to be transferred back from the second culture vessel. The second culture vessel is then sterilized and neutralized.
Patent SG-12695-G (SG)
Title: Substituted (quinoline-2-yl-methoxy) phenyl-acyl-sulphonamides and cyanamides process for their preparation and their use in medicines
Inventor: RADDATZ SIEGFRIED DR
IPC: C07D215/14
Filed: 1995-01-26
Abstract: The novel (quinolin-2-ylmethoxy)phenylacylsulphonamides and -cyanamides can be prepared by amidating corresponding (quinolin-2-ylmethoxy)phenylcarboxylic acids with sulphonamides or cyanamides. The (quinolin-2-ylmethoxy)phenylacylsulphonamides can also be obtained according to one process variant by reacting (quinolin-2-ylmethoxy)phenylacylamides with sulphonyl halides. The (quinolin-2-ylmethoxy)phenylacylsulphonamides and -cyanamides can be employed as active substances in medicines, in particular as lipoxygenase inhibitors.
Patent SG-80184-G (SG)
Title: Injection moulding machine
IPC: B29C45/53
Filed: 1984-11-09
Abstract: In a machine for the continuous and automatic production of a succession of small components from synthetic plastics material by injection moulding, the mould and injection unit are operatively connected to a common actuating device through two separate transmission mechanisms which both include an element reciprocable along the longitudinal axis of the machine and are so interconnected that the injection unit cannot operate until the mould has been closed.
Patent IE-800328-L (IE)
Title: Pinball game apparatus
IPC: A63F7/02
Filed: 1980-02-20
Abstract: An alternate target configuration is disclosed for a pinball game apparatus or the like, where two adjacent targets are mounted within a frame on the underside of the apparatus playfield, each adapted to move through a playfield opening between an exposed position above the playfield and a hidden position below the playfield. A linkage including an elongated member medially pivoted to the frame in the fashion of a seesaw is connected at its opposite ends to the respective targets, preferably when one target is exposed and the other target is hidden. The linkage is effective to shift both targets simultaneously from one alternate target position to another alternate target position where the other target is exposed and the one target is hidden. A spring toggles the seesaw linkage resiliently to the extreme limit of travel in each alternate target position. A motor overrides the spring toggle through an alternately reversed ratchet type connection to shift the seesaw linkage and reverse the positions of the targets. The motor is activated responsive to the exposed target being hit by the ball, and appropriate scoring apparatus is then energized.
[US4243222A]
Patent IE-44564-L (IE)
Title: DITHIEPINO [1,4] [2,3-c] PYRROLE DERIVATIVES
IPC: A61K31/496
Filed: 1977-02-17
Abstract: Compounds of the formula: <IMAGE> wherein A represents a phenyl, pyrid-2-yl, quinol-2-yl or 1,8-naphthyridin-2-yl radical, each such radical being optionally substituted by a halogen atom, an alkyl radical of 1 through 4 carbon atoms, an alkoxy radical of 1 through 4 carbon atoms, the cyano or nitro radical, and R represents hydrogen or an alkyl radical of 1 through 4 carbon atoms, an alkenyl radical of 2 through 4 carbon atoms or an alkanoyl radical of 1 through 4 carbon atoms, possess pharmacological properties and are particularly active as tranquillizers, anti-convulsant agents, decontracturants and agents to produce hypnosis.
[US4124711A]
Patent IE-810455-L (IE)
Title: Amidines
IPC: C07D487/04
Filed: 1981-03-03
Abstract: Novel amidines, especially N,N'- bridged carboxylic acid amidines of the general formula   <IMAGE> in which R1 represents an aromatic radical, R2 represents optionally esterified or amidated 1-carboxy- lower alkyl, Ph represents optionally substituted 1,2-phenylene and alk represents an aliphatic hydrocarbon radical separating the imino group from the methane group by from 1 to 3 carbon atoms, and their salts, have, inter alia, anti-inflammatory activity and can be used as active medicament substances in pharmaceutical preparations. They are produced according to methods known per se.
Patent IE-800733-L (IE)
Title: Preparation of pancreatin pellets
IPC: C12N9/94
Filed: 1980-04-10
Abstract: Pancreatin pellets are produced by a process employing extrusion techniques. In the process, a mixture of pancreatin powder and selected solvent is formed into a pliable mass suitable for extrusion. The extrusion is conducted followed by a cutting, shaping or forming of the extruded mass into pre-pellet like forms. Further drying and mechanical working of the pre-pellet forms results in the final pancreatin pellet of improved pharmaceutical and mechanical stability. A special aspect of the process is the selection of a solvent for mixing with pancreatin powder that is harmless to enzymes. Such solvents typically include isopropanol and acetone.
[US4280971A]
Patent IE-32166-L (IE)
Title: Herbicides; bipyridylium complexes
IPC: C07D213/22
Filed: 1968-07-01
Abstract: 1,230,566. Complexes of bipyridylium quaternary salts. IMPERIAL CHEMICAL INDUSTRIES Ltd. 17 June, 1968 [10 July, 1967], No. 31669/67. Heading C2C. [Also in Division A5] The invention comprises solid complexes of a herbicidal bipyridylium quaternary salt and 1-4 molecular proportions of a complexing agent which contains an aromatic or heterocyclic nucleus bearing one or more hydroxy, amino or mercapto group, being other than p-phenylene diamine, aniline or hydroquinone. The complexes are prepared by mixing the components in aqueous or alcoholic solution, a solid product crystallizing immediately or on evaporation of the solvent. Complexes prepared in aqueous media often contain water as lattice hydration. Anhydrous products are obtained by drying, e.g., at 100‹ C. Specified complexing agents are p-aminophenol, catechol, phloroglucinol, 3,4- dihydroxybenzoic acid, p-aminobenzoic acid, α - naphthylamine, o - aminobenzenethiol, 2- mercaptopyridine, and 2-mercapto-benzimidazole. Examples relate to complexes of 1,1<SP>1</SP>- dimethyl - 4,4<SP>1 </SP>- bipyridylium dichloride, diphloroglucinate and di-p-nitrophenate, 1,1<SP>1</SP>- di - (2 - hydroxyethyl) - 4,4<SP>1 </SP>- bipyridylium dichloride and 1,1<SP>1 </SP>- di - (3,5 - dimethylmorpholinocarbonylmethyl) - 4,4<SP>1</SP> - bipyridylium dichloride. The complexes possess herbicidal properties.
[GB1230566A]
Patent IE-870789-L (IE)
Title: Coatable ion exchange resins
IPC: A61K9/18
Filed: 1987-03-26
Abstract: Sulfonic acid cationic exchange resin particles which have been treated to improve their coatability with up to about 20% by weight of a compound selected from hydroxypropylmethyl cellulose, hydroxypropyl cellulose, hydroxypropyl sorbitol, sorbitol, and polyvinylpyrrolidone.
Patent IE-820805-L (IE)
Title: Joystick control
IPC: G05G9/047
Filed: 1982-04-05
Abstract: A manually-operable joystick is mounted for universal pivoting motion as by means of spherical bearing and journal means and is biased toward a neutral position so as to return automatically thereto upon release of manual constraint.
[US4375631A]
Patent IE-790997-L (IE)
Title: Flow distributor for fluid bed reactors
IPC: C02F3/00
Filed: 1979-08-08
Abstract: A flow distributor for a fluid bed reactor includes means for decreasing velocity of incoming liquid streams in a uniform, non-turbulent fashion. Inlet ports communicate with fluid portals having divergent walls to slow incoming flow. The fluid portals feed liquid flow to a plurality of diffusing flow paths provided between diffusion baffles positioned at the bottom of the reactor. The diffusion baffles may be prismatic shapes which are trapezoidal in cross-section with the broadest horizontal dimension at the bottom thereof. The diffusion flow paths therefore have divergent walls and act to further slow the liquid flow passing therethrough.
[US4202774A]
Patent FI-810027-L (FI)
Inventor: KUNG PATRICK CHUNG-SHU
IPC: G01N33/50
Filed: 1981-01-07
Abstract: Hybrid cell line for production of monoclonal antibody to an antigen found on normal human monocytes and granulocytes. The hybrid is formed by fusing splenocytes from immunized BALB/cJ mice with P3X63Ag8U1 myeloma cells. Diagnostic and therapeutic uses of the monoclonal antibody are also disclosed.
Patent IE-32359-L (IE)
Title: Antibacterial composition
Filed: 1968-09-11
Abstract: 1,244,024. Antibacterial compositions. BRISTOL-MYERS CO. 19 Sept., 1968 [20 Sept., 1967], No. 44519/68. Heading A5B. A composition for treating bacterial infection comprises 15-110 parts by weight of amphotericin B to 100-550 parts by weight of ampicillin or hetacillin. A preferred dosage unit comprises 15-110 mg. of amphotericin B per unit dose and 100-550 mg. of hetacillin or ampicillin per unit dose. Preferably the composition is reconstituted with water for use, and contains a buffer to maintain the pH at 2-8 (preferably 2-3 with hetacillin; 5-8 with ampicillin). Conventional sequestering agents, suspending agents, sweetening agents, colouring and flavouring agents, anti-oxidants or preservatives may be included (many examples given).
[GB1244024A]
Patent IE-791167-L (IE)
Title: Storage and serving container
IPC: B65D85/50
Filed: 1979-08-08
Abstract: A container having a slidable article-removing internal insert which consists of a tray and a projecting handle that is so constructed to be guided for unobstructable movement within the container receptacle. Moreover, the means for such guided movement is incorporated into the handle arrangement of the insert in a fashion that positively restrains the insert for virtually the whole extent of its travel in the receptacle.
[US4179040A]
Patent IE-44307-L (IE)
Title: Vesiculated silica microspheres
IPC: D21H21/54
Filed: 1976-06-09
Abstract: Vesiculated silica microspheres having an average diameter from 0.5.mu. to 50.mu., a maximum vesicle diameter less than 50.mu. and a volume of vesicles from 5 to 95% of the total volume of the microspheres, produced by acidifying an oil-in-water-in-oil emulsion prepared by a double emulsion technique. The vesiculated silica microspheres are particularly useful as opacifying agents for coating compositions and as fillers for paper.[US4011096A]
Patent IE-781243-L (IE)
Title: Optical fibre connector
IPC: G02B6/38
Filed: 1978-06-21
Abstract: The invention relates to an optical fibre connector. A short segment of fibre with a diameter which is accurately known and which is held in the connector is connected by welding to the end of a very long transmission fibre. Application to telecommunications.
[US4220394A]
Patent IE-39507-L (IE)
Title: Closed circuit distribution system
IPC: H04N7/173
Filed: 1974-06-17
Abstract: In two-way cable television systems, return channel noise inherently limits the number of permissible subscribers. The apparatus of this invention reduces the return noise from subscribers not using the service by means of an adaptive return path amplifier, through carrier operated squelch control or through digital interrogation control.[US3886454A]
Patent IE-791362-L (IE)
Title: Accumulator electrodes
IPC: H01M4/62
Filed: 1979-08-08
Abstract: Negative electrode supports in the form of a frame with bars have gaps such that the ratio between the total length of the bars in cm divided by the overall area of the plate in cm<2> is less than 1.5, the paste includes fibres 6 to 25 mm long which constitute between 0.25% and 1.5% the weight of the paste.
[GB2027555A]
Patent IE-841617-L (IE)
Title: PYRAZOLO (3,4,5-kl) ACRIDINE
IPC: C07D471/04
Filed: 1984-06-26
Abstract: Pyrazolo[3,4,5-kl]acridines are described as antibacterial agents and antitumor agents as well as pharmaceutical compositions and methods for their preparation.
Patent IE-841722-L (IE)
Title: Die unit for extrusion of metal
IPC: B21C25/02
Filed: 1984-07-06
Abstract: A die unit for extrusion apparatus, especially Conform apparatus, comprises a die 10 and die holder 11. The die is supported in the holder but is surrounded over at least a substantial part of its length by a sleeve 12 extending from the working face between the die and the die holder and made of a metal soft compared with the die and the die holder. Suitable metals are mild steel and the metal being extruded. Round wire can be formed.
[EP0131426A2]
Patent IE-801783-L (IE)
Title: Treatment of liquid metals.
IPC: C22B9/05
Filed: 1980-08-22
Abstract: The invention concerns an apparatus for active filtration and treatment of liquid metals and alloys and particularly to the purification of aluminum, magnesium, or alloys based on aluminum or magnesium, prior to molding. It comprises a detachable cartridge, closed at at least one end by a porous block based on grains of fritted flux and filled with grains of flux, solid at the temperature of the metal to be filtered. The cartridge may include a means for injecting an active or inert gas into the grains; it may be arranged in a heated, heat insulated ladle.
Patent IE-871833-L (IE)
Title: Combination dosage form of steroids
IPC: A61K31/565
Filed: 1987-07-08
Abstract: Disclosed herein is a method of providing hormonal replacement therapy and contraception for a pre-menopausal woman, which comprises administering to a pre-menopausal woman in need thereof a combination dosage form of an estrogen selected from  0.5-2.0 mg. of 17 beta -estradiol,  0.008-0.030 mg. of ethinyl estradiol, and  0.015-0.060 mg. of mestranol;  and a progestogen selected from  0.025-0.100 mg. of levonorgestrel,  0.010-0.070 mg. of gestodene,  0.025-0.100 mg. of desogestrel,  0.025-0.100 mg. of 3-ketodesogestrel, and  0.085-0.35 mg. of norethindrone, said combination dosage form being administered for 23-25 days beginning at day one of the menstrual cycle, followed by 2-5 pill-free or blank pill days, for a total of 28 days in the administration cycle. The preferred dosage form of the invention is a combination of 1 mg. of 17 beta -estradiol and 0.050 or 0.075 mg. of levonorgestrel. The preferred administration cycle of the invention is administration of the combination dosage form for the first 24 days of the menstrual cycle and no dosage form for the last 4 days of the menstrual cycle.
Patent IE-872260-L (IE)
Title: Dual compartment anode structure for use in a molten¹carbonate fuel cell
IPC: H01M8/06
Filed: 1987-08-24
Abstract: A dual compartment anode structure for use in molten carbonates fuel cells having an electrolyte porous metallic plate structure (14) with one face (14a) adapted to contact the electrolyte (13) and an opposite face having a plurality of ribs (14b) extending therefrom, a hydrogen ion and molecular hydrogen and electrolyte non-porous metallic foil (15) having one face in contact with the ends of the ribs to define an anode reaction gas compartment (22) therebetween, and a corrugated metallic current collector (16) having a plurality of peaks with one face at the peaks in contact with the opposite face of the metallic foil defining an anode fuel gas compartment (21) therebetween. The dual compartment anode structure of this invention provides separation between the electrolyte and the fuel thereby permitting internal cell reforming of hydrocarbon containing fuels without poisoning of the reforming catalyst and provides greater cell stability due to reduction in corrosion and reduced electrolyte and electrode loss.
Patent IE-852408-L (IE)
Title: Antibiotic composition
IPC: A61K31/65
Filed: 1985-10-01
Abstract: Oxytetracycline aqueous solutions, particularly for parenteral administration containing N-Methylpyrollidone as a solvent are disclosed.
[US4772460A]
Patent IE-42103-L (IE)
Title: Polymeric dye-receptive additives
IPC: D01F1/10
Filed: 1975-11-14
Abstract: 1522706 Dye-receptive polymers BAYER AG 31 Oct 1975 [15 Nov 1974] 45246/75 Heading C3P A dye-receptive polymer comprises (A) 4 to 10 mol.% of an acrylic or methacrylic acid amide corresponding to the general Formula (I) in which R1 represents H or CH3, R2 represents a linear or branched alkylene radical, optionally substituted by an aryl group, or an arylene radical, and M represents a primary, secondary, tertiary or quaternary ammonium group, a lithium cation or a magnesium cation equivalent; (B) 10 to 50 mol.% of vinyl chloride, vinylidene chloride or vinyl bromide, and (C) 30 to 80 mol.% of at least one other halogenfree compound of general Formula (II) in which R3 represents H or CH3, and R4 represents the group -C#N, where R5 is C1 to C4-alkyl, or the group where R5 is C1 to C4-alkyl, and R6 represents H or CH3. The polymer is produced in an amide containing aprotic solvent, e.g. dimethyl formamide or dimethyl acetamide containing up to 10% by weight of water. Examples are given in which (a) 2-acrylamido-2-methylpropane sulphonic acid /2-methylaminoethanol salt is copolymerized with vinyl or vinylidene chloride and acrylonitrile, methyl methacrylate or N- tert.butyl acrylamide and (b) 4-methylacrylamidobenzene sulphonic acid/triethylamine salt is copolymerized with vinylidene chloride and acrylonitrile.
[GB1522706A]
Patent IE-853231-L (IE)
Title: Turnstile
IPC: A61K/
Filed: 1985-12-18
Abstract: A method for preparing a stable aerosol formulation of beclomethasone dipropionate in which the steroid is contacted with an alcohol containing 1 to 5 carbon atoms to form a crystalline solvate therewith, the crystalline material so formed being reduced to a particle size below 10 microns and thereafter dispersed in a composition comprising chlorofluorocarbon propellents.
[WO8603750A1]
Patent NO-821287-L (NO)
Inventor: COMI GAETANO
IPC: C12N9/64
Filed: 1982-04-21
Abstract: A natural active principle enzymatic in type, called angiokinase, is obtained with an extraction procedure starting from mammalian connective tissue, such as from cattle and the like. The active principle comprises a new drug for the prophylaxis and treatment of all symptoms of abnormal fibrin formation and thrombus formation in various sites and localizations, such as atherosclerotic diseases and diabetic retinopathy, as well as thrombosis and thromboembolisms.